By surface electroporation, BACE1 siRNA was loaded into exosomes, and then intravenously administered to AD model mice, where it suppressed BACE1 mRNA and protein expression and, in turn, reduced amyloid-beta (A) peptide synthesis in AD mice. This evidence concerns the gene BACE1 and Alzheimer disease.